|
Accession number;04A0592328
|
| Title;Out-hospital Patients with Hyperlipidemia and Hepatitis with Various Backgrounds Improved by Wheat Protein Hydrolysate (Glutamine Peptide) Administration |
| Author;
HORIGUCHI N
(Horiguchi Clinic)
HORIGUCHI H
(Horiguchi Clinic)
SUZUKI Y
(Nissin Pharma Inc.)
|
Journal Title;Japanese Pharmacology & Therapeutics
|
Journal Code:Z0947A
|
ISSN:0386-3603
|
|
VOL.32;NO.7;PAGE.415-420(2004)
|
| Figure&Table&Reference;TBL.1, REF.11 |
| Pub. Country;Japan |
| Language;English |
| Abstract;We encountered an outpatient with steatohepatitis showing an improvement with a wheat protein hydrolysate (glutamine peptide) administration. The improvement in hepatitis and reductions in liver fat accumulation were observed within 1 week. When the administration of wheat protein hydrolysate was discontinued, levels of GOT, GPT and .GAMMA.-GTP increased, and when administration was resumed, levels of these enzymes decreased. Glutamine peptide was therefore administered to steatohepatitic patients with background factors such as hyperlipidemia, diabetes, obesity, hepatitis C, and hepatitis B. Within 4 weeks, improvements in hepatitis and reductions in liver fat accumulation were observed. Improvements in serum lipid levels were also observed in patients with hyperlipidemia. (author abst.) |
|
|
|
Related Articles;
|
